Manlangit, Baby Boy .
HRN: 26-44-82 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
01/06/2025
AMPICILLIN 1GM (VIAL)
01/06/2025
01/13/2025
IV
160mg
Q12h
PSNB
Waiting Final Action
01/06/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
01/06/2025
01/13/2025
IV
48mg
Q24h
PSNB
Waiting Final Action
01/06/2025
CEFOTAXIME 500MG (VIAL)
01/06/2025
01/13/2025
IV
160mg
Q12h
PSNB
Waiting Final Action
01/15/2025
MUPIROCIN 2%, 15G (TUBE)
01/15/2025
01/22/2025
SKIN
0.5mg
BID
Phlebitis
Waiting Final Action